Scientific Program -OLD

SCIENTIFIC PROGRAM

Abstract Submission

Abstract Submission Topics

  • Antimicrobial resistance & AMS
  • Bioterrorism and biological warfare
  • Big Data, Genomics and Outbreaks
  • Climate change and ecological factors in disease emergence
  • COVID-19 Pathogenesis
  • COVID-19 Diagnostics and therapeutics
  • COVID-19 Vaccines
  • COVID-19 Infection Prevention and Control
  • COVID-19 Big Data, surveillance and contact tracing
  • COVID-19 Ethics and Misinformation
  • Diseases of animals
  • Ethical Issues in Infectious Diseases
  • Education advancements in One Health
  • Emerging and neglected zoonotic diseases
  • Emerging infectious diseases in displaced populations
  • Foodborne and waterborne diseases
  • Inequalities and access in infectious diseases
  • Infections related to travel and migration
  • Infection Prevention and Control
  • Influenza and other respiratory infections
  • Innovations in diagnostic tests for emerging diseases
  • New approaches to outbreak surveillance and monitoring
  • New pathogen discovery
  • Outbreak modeling and forecasting
  • Outbreak response and control
  • Outbreak control and response logistic challenges
  • One Health in Action
  • Political factors in disease emergence and response
  • Public communication of outbreaks and emerging diseases
  • Rumors and misinformation in infectious diseases
  • Vaccines and emergence of vaccine preventable diseases
  • Vector Borne diseases
  • Other

Authors with original research are encouraged to submit abstracts related to the above mentioned topics and related fields of investigation. After the conclusion of the conference, high ranking abstracts will be published in a supplement to the International Journal of Infectious Diseases (IJID).

Abstract Submission Guidelines

  • Abstract submission deadline: June 30, 2021
    This will allow the most timely and up-to-date abstracts to be presented at IMED. Now is the time to submit your abstracts. Accepted abstracts may be presented as ePosters, and select abstracts will be presented as virtual oral presentations.
  • Abstracts acceptance / rejection notifications will be sent by August 31, 2021.
  • Authors are requested to submit abstracts in ENGLISH.
  • Abstracts must be submitted online.
  • The abstract should not exceed 350 words without a presentation title. Abstracts that do not comply will be disqualified from IMED.
  • Abstracts will be selected for either an ePoster presentation or an oral, virtual presentation. Selection will be made based on reviewer scores.
  • Abstract titles should not be longer than two lines and should NOT be in all caps but Title Case
    (e.g. correct: Virological Investigations in Native Bat Species from Germany)
  • All abstracts must be structured as follows:
    Purpose: A statement of the hypothesis or research question.
    Methods & Materials: An explanation of the study design and experimental methods & materials used.
    Results: A concise summary of the major findings of the experiment or study. Sufficient data must be provided to permit evaluation by the reviewers and public reading the abstracts.
    Statements such as “additional information to be presented at the meeting” are not acceptable.
    Conclusion: Summary of the overall findings and the importance of the study.
  • Each abstract will be reviewed and scored by at least two reviewers. More than 50 reviewers representing 30+ countries will be involved in the review and scoring process. The accepted abstract will be assigned to appropriate ePoster or oral sessions. A notification will be emailed to the abstract submitter.
  • All authors who wish to present their abstract at IMED 2021 must pay the conference registration fee.
  • Please contact ISID, Doris Steinbach, if you have any questions regarding abstract submissions (email: [email protected])

Planned Session Topics

Summary

Emerging infectious diseases are, more than ever, at the center of the world’s attention. Join a diverse group of colleagues from around the world as they present new knowledge and breakthroughs about how to discover, detect, understand, prevent and respond to outbreaks of emerging disease threats.

Target audience

Healthcare professionals including physicians and veterinarians, public health professionals, epidemiologists, research scientists, environmentalists, biotechnology industry, journalists, and policy makers.

 Planned session topics include:

  • One Health challenges in the Infectious Diseases Community
  • Emerging infectious diseases in humans and animals and the “One Health” concept
  • Methods and models of disease surveillance, detection, and prediction
  • COVID-19 updates and lessons learned
  • COVID-19 Vaccine Development Round Table
  • Emerging zoonoses and animal health threats
  • Biosecurity and agents of bioterrorism and biological warfare
  • Infections related to travel and migration of humans and animals
  • Advanced diagnostic technologies for emerging infectious diseases
  • Foodborne and waterborne pathogens
  • Specific disease threats: Pandemic Avian, and Swine Influenza; Ebola, Yellow Fever, Lassa, and other Viral Hemorrhagic Fevers; antimicrobial-resistant pathogens, Anthrax, plague; healthcare-associated Infections; Coronaviruses: SARS-CoV, MERS-CoV, SARS-CoV-2; Pandemic impact on HIV/TB, vaccination programs, and antimicrobial resistance.
  • Vaccines and therapeutics for emerging diseases
  • Social, political, and economic factors in disease emergence
  • Epidemic/Pandemic preparedness and response
  • Neglected emerging threats: Snake bites, rabies, marine toxins, and fungal pathogens
  • Submitted abstracts (oral and poster)

* Planned topics are subject to change!

Scientific Program

The program is subject to change!

Pre-recorded Sessions will be made live every evening at midnight EST for registered/paid attendees and can be viewed any time during the conference period and will be available for 3 months after conclusion of the conference. Q&A periods will not be live and questions can be sent to presenters which will be answered via email.

All Plenary Sessions and Q&A periods will be live (EST) and can be attended by registered/paid attendees.